Gregor Zwink-Schweighofer

Salzburg, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei.

Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei.

Journal: Haematologica

Published: August 07, 2025

Optimized Automated Cassette-Based Synthesis of [68Ga]Ga-DOTATOC.

Optimized Automated Cassette-Based Synthesis of [68Ga]Ga-DOTATOC.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 05, 2025

Additional diagnostic information and interobserver reliability of late imaging 120 minutes after tracer application in MAG3 scintigraphies in children with unilateral hydronephroses.

Additional diagnostic information and interobserver reliability of late imaging 120 minutes after tracer application in MAG3 scintigraphies in children with unilateral hydronephroses.

Journal: Journal of pediatric urology

Published: August 01, 2025

Rechallenge and Extended [177Lu]Lu-PSMA Therapy in Metastatic Prostate Cancer.

Rechallenge and Extended [177Lu]Lu-PSMA Therapy in Metastatic Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 17, 2025

Artificial Intelligence for Tumor [18F]FDG PET Imaging: Advancements and Future Trends - Part II.

Artificial Intelligence for Tumor [18F]FDG PET Imaging: Advancements and Future Trends - Part II.

Journal: Seminars in nuclear medicine

Published: June 18, 2025

Use of 177Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer : Joint statement of the Austrian Society of Nuclear Medicine and Theranostics and the Austrian Society of Urology and Andrology.

Use of 177Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer : Joint statement of the Austrian Society of Nuclear Medicine and Theranostics and the Austrian Society of Urology and Andrology.

Journal: Wiener klinische Wochenschrift

Published: April 17, 2025

Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma.

Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma.

Journal: The British journal of dermatology

Published: December 23, 2024

Fibroblast Activation Protein Inhibitor (FAPI)-Radioligand PET/CT in the Assessment of Nononcological Diseases: A Narrative Review.

Fibroblast Activation Protein Inhibitor (FAPI)-Radioligand PET/CT in the Assessment of Nononcological Diseases: A Narrative Review.

Journal: ACS pharmacology & translational science

Published: November 05, 2024

B-CLL with negative 18F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases.

B-CLL with negative 18F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases.

Journal: EJNMMI reports

Published: October 28, 2024

Bone Mineral Density and First Line Imaging with [18F]fluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center.

Bone Mineral Density and First Line Imaging with [18F]fluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center.

Journal: Diagnostics (Basel, Switzerland)

Published: August 22, 2024

[68Ga]Ga-FAP-2286-Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma.

[68Ga]Ga-FAP-2286-Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 30, 2024

18F-FDG PET/CT in assessment of paraneoplastic cerebellar degeneration as the first sign of occult fallopian tube serous cystadenocarcinoma: Case report.

18F-FDG PET/CT in assessment of paraneoplastic cerebellar degeneration as the first sign of occult fallopian tube serous cystadenocarcinoma: Case report.

Journal: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Published: April 16, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026